Glenn Wilkins - Monday, June 22, 2020 ESSA Pharma Inc. 09:55 AM EST - ESSA Pharma Inc. : Presented new preclinical data on ESSA's clinical candidate, EPI-7386, at the 2020 American Association for Cancer Research Virtual Annual Meeting II. ESSA Pharma Inc. shares V.EPI are trading unchanged at $7.00.